Viewing Study NCT04571567


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-03-11 @ 2:53 PM
Study NCT ID: NCT04571567
Status: COMPLETED
Last Update Posted: 2022-04-11
First Post: 2020-09-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis
Sponsor: Saakshi Khattri
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module